Guest: Arthur Holden, MBA
Host: Bruce Japsen
Two years after it was formed, the International Serious Adverse Event Consortium, working with the U.S. Food and Drug Administration, is making progress understanding why certain people are predisposed to dangerous drug interactions. Arthur Holdren, founder of the consortium, tells host Bruce Japsen about the discovery of a genetic link between liver injury and some people who received a popular antibiotic.
